Literature DB >> 35394558

Hsa_circ_0008344 Promotes Glioma Tumor Progression and Angiogenesis Presumably by Regulating miR-638/SZRD1 Pathway.

Liyong Deng1, Kuiyu Gong1, Guihua Wang2.   

Abstract

Hsa_circRNA_0008344 (circ_0008344) is a new glioma-related circular RNA. Our study aims to explore its functions in glioma tumor progression. Real-time quantitative PCR and western blotting were used to detect RNA and protein abundances. RNase R assay, actinomycin D assay, and subcellular fractionation method were performed to identify the features of circ_0008344. Cell-counting kit-8, 5-ethynyl-2'-deoxyuridine assays, transwell assays, tube formation assay, flow cytometry, and nude mice xenograft tumor model were performed. Target relationship was predicted by bioinformatics algorithms and confirmed by dual-luciferase reporter assay. Abundances of circ_0008344 and SUZ RNA binding domain containing 1 (SZRD1) were highly elevated, while miR-638 was downregulated in glioma tumors and cells. Circ_0008344 was identified as a stable circRNA with a circular structure. Silencing circ_0008344 could restrain glioma proliferation, migration, invasion, and angiogenesis. Circ_0008344 functioned as a sponge for miR-638. The negative regulation of circ_0008344 knockdown on glioma progression and angiogenesis could be reversed by miR-638 inhibitor. SZRD1 was a target of miR-318, and its overexpression overturned the inhibition effect of miR-638 mimic on glioma progression and angiogenesis. Meanwhile, we confirmed that circ_0008344 knockdown inhibited SZRD1 expression, and its effect was reversed by miR-638 inhibitor. Also, circ_00008344 knockdown suppressed glioma tumor growth. Circ_0008344 might contribute to glioma progression through miR-638/SZRD1 axis, which might be a novel pathology and treatment target in glioma.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Angiogenesis; Circ_0008344; Glioma; SZRD1; miR-638

Mesh:

Substances:

Year:  2022        PMID: 35394558     DOI: 10.1007/s12640-022-00504-8

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  21 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach.

Authors:  Hugues Duffau; Luc Taillandier
Journal:  Neuro Oncol       Date:  2014-08-02       Impact factor: 12.300

3.  Phosphatidylinositol-3-OH kinase as a direct target of Ras.

Authors:  P Rodriguez-Viciana; P H Warne; R Dhand; B Vanhaesebroeck; I Gout; M J Fry; M D Waterfield; J Downward
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

Review 4.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

Review 5.  Epigenetic-sensitive liquid biomarkers and personalised therapy in advanced heart failure: a focus on cell-free DNA and microRNAs.

Authors:  Gelsomina Mansueto; Giuditta Benincasa; Nunzia Della Mura; Giovanni Francesco Nicoletti; Claudio Napoli
Journal:  J Clin Pathol       Date:  2020-07-02       Impact factor: 3.411

6.  hsa_circ_0000177-miR-638-FZD7-Wnt Signaling Cascade Contributes to the Malignant Behaviors in Glioma.

Authors:  Zhiqiang Chen; Xingbang Duan
Journal:  DNA Cell Biol       Date:  2018-07-16       Impact factor: 3.311

7.  Tectal glioma harbors high rates of KRAS G12R and concomitant KRAS and BRAF alterations.

Authors:  Jason Chiang; Xiaoyu Li; Anthony P Y Liu; Ibrahim Qaddoumi; Sahaja Acharya; David W Ellison
Journal:  Acta Neuropathol       Date:  2019-12-10       Impact factor: 17.088

8.  SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway.

Authors:  Xiaobai Liu; Shuyuan Shen; Lu Zhu; Rui Su; Jian Zheng; Xuelei Ruan; Lianqi Shao; Di Wang; Chunqing Yang; Yunhui Liu
Journal:  J Exp Clin Cancer Res       Date:  2020-06-29

9.  The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells.

Authors:  Yang Jiang; Jinpeng Zhou; Junshuang Zhao; Haiying Zhang; Long Li; Hao Li; Lian Chen; Jiangfeng Hu; Wei Zheng; Zhitao Jing
Journal:  J Exp Clin Cancer Res       Date:  2020-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.